BC Environmental and Occupational Health Research Network

The Mythbusters Award provides an opportunity to write for publication an issue of Mythbusters – a series of reader-friendly research summaries addressing some of today’s major debates in Canadian health services management and policy.

This award will provide one year of funding of USD 55,000 for research grant applications that address a high priority research area for JDRF, failed to receive funding but scored within 10% of the funding payline for a review cycle of a research funding agency up to a year prior to the request to JDRF. The goal of this bridge funding is to help investigators generate additional supporting data for an amended, competitive application.

The AACR-FNAB Career Development Award for Translational Cancer Research is open to junior faculty who are in the first four years of a faculty appointment (at the start of the grant term). Research projects are restricted to translational cancer research focused on any individualized therapeutic area. Proposed project must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. In vivo primary tumor explants meet these criteria, but xenografts from established cell lines do not. This is a two-year grant of $100,000 ($50,000 per year) for direct research expenses and salary support.

The AACR-Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award provides a one-year grant of $50,000 to support direct research expenses, which may include the salary and benefits of the grant recipient, postdoctoral or clinical research fellows and/or research assistants, research/laboratory supplies, and equipment. The purpose of this award is to fund physician-scientists during the transition from a fellowship program to a faculty appointment. The Award is open to physicians (M.D., D.O., or international equivalent) or physicians holding a combined M.D./Ph.D. Applicants must be working in an oncology laboratory or clinical research setting in an academic medical institution and be in the last two years of his/her final subspecialty training. Research projects are restricted to translational cancer research.

Cross discipline research is encouraged in the following thematic areas:
• Mitigating occupant injury and disability in motor vehicle collisions or automotive manufacturing
• Prevention of disability resulting from vehicular or automotive manufacturing injuries
The research focus must address one of the following areas related to the above themes:
• Advances in injury prevention
• Effective situational diagnosis and management
• Reliable and valid measurement tools to evaluate and improve safety design methodologies, and future research
• Effective research dissemination and utilization practices
• Evaluation of design, evidence formed methodologies or interventions targeted at reducing impairment and disability

The AACR-FNAB Career Development Award for Translational Cancer Research is open to junior faculty who are in the first four years of a faculty appointment (at the start of the grant term). Research projects are restricted to translational cancer research focused on any individualized therapeutic area. Proposed project must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. In vivo primary tumor explants meet these criteria, but xenografts from established cell lines do not. This is a two-year grant of $100,000 ($50,000 per year) for direct research expenses and salary support.

Through the Institute Community Support (ICS) Program, the CIHR Institutes are launching the ICS Travel Awards competition for students, postdoctoral fellows, new investigators and knowledge users to present their own research at national and international meetings and/or conferences.
This ICS Travel Awards competition will not support travel for research skills development or update, exchange programs or lectureships.
Please note that each of the participating Institutes have their own specific Research Foci, Eligibility Requirements and Funding Levels, which are outlined in the "Partner Description" section of this funding opportunity.

The objective of the New Investigator Salary Award program is to provide outstanding new investigators with the opportunity to develop and demonstrate their independence in initiating and conducting health research through provision of a contribution to their salary.

These projects are expected to take existing evidence and transition it into an intervention research project. A central focus of this funding program and the reason for its prioritization by the Canadian Cancer Society Prevention Initiative, is to provide an opportunity to build on existing cancer research findings and turn them into cancer prevention action. Applications are invited from current Canadian Cancer Society Research Institute grant holders across all disciplines to submit pilot studies that will translate their research findings into identifying effective interventions that reduce the cancer incidence in the human population.

The AACR-Aflac, Inc. Career Development Award for Pediatric Cancer Research represents a joint effort to encourage and support junior faculty who are in the first 4 years of a faculty appointment (at the start of the grant term) to conduct pediatric cancer research and establish successful career paths in this field. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pediatric cancer.
The Award provides $100,000 over two years ($50,000 per year) for direct research expenses, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, and/or research assistants, research/laboratory supplies and equipment.

The CIHR Partnership Award, established in 2002, recognizes partnerships between organizations that exemplify excellence by bringing health research communities together to create innovative approaches to research, develop research agendas that are responsive to the health needs of Canadians and/or accelerate the translation of knowledge for the benefit of Canadians. The emphasis of the award is on innovative cross-sectoral partnerships that promote excellence.
Recipient(s) will receive a $25,000 award in the form of a one-year research grant, to be used by the awardee(s) to advance the research or knowledge translation activities of the partnership. Winners agree to be highlighted on the CIHR website, in communication materials and included in a commemoration of all CIHR award winners at CIHR’s corporate office. In addition, the partnership may be written up as a "best practice" for the CIHR partnership casebook.

This award is directed at clinician-scientists who have completed doctoral level research training and who are newly appointed as a clinician-scientist (within two years of completing their research training) based in one of the participating Child Health Research Training Centres of the Canadian Child Health Clinician Scientist Program. The award will facilitate guarantee of protected time during early career development within a mentored research program. A minimum of 75% time commitment to research is expected.

These two-year awards will provide a total of $1 million per team. Challenge Awards support large-scale research projects. Proposals must be from teams of at least 3 highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research. A team may be assembled from one institution, or several institutions, from across the globe.
This round of awards will focus on funding Treatment Science: studies of new ideas in man or laboratory support of a high impact clinical investigation.

The Mythbusters Award provides students with the opportunity to write for publication an issue of Mythbusters – a series of reader-friendly research summaries addressing some of today’s major debates in Canadian health services management and policy.
The winner will receive
• an award of $1,500
• the opportunity to work with CHSRF staff to prepare his or her Mythbusters topic for publication
• travel, accommodations and registration to the 2011 Canadian Association for Health Services and Policy Research (CAHSPR) annual conference in Halifax, Nova Scotia (May 9 to 12, 2011) to receive the award.

The Garfield Weston Foundation Awards are two grants focusing on projects that advance evidence-based research in pertinent female reproductive health issues. The 2011 Awards are concentrated on the area of obesity and reproductive health.

The Prostate Cancer Foundation (PCF) is now accepting applications for the PCF 2011 Creativity Awards. This funding mechanism will provide two years of support (up to $150,000 per year for direct costs only) for highly innovative prostate cancer research proposals that are not fundable by other existing mechanisms.
This round of awards will focus on funding Treatment Science: studies of new ideas in man or laboratory support of a high impact clinical investigation.

The purpose of this award is to bring new, creative investigators into active research on the health effects of air pollution. It provides three years of funding for a small project relevant to HEI’s research interests to a new investigator with outstanding promise at the Assistant Professor or equivalent level. Applicants should contact HEI to check their eligibility.

The field of cancer prevention research is rapidly advancing and evolving. To sustain the advancement of the field and the development of new thinking and strategies, younger investigators must be encouraged to pursue cancer prevention research, yet few vehicles exist to recognize their accomplishments or support their early research efforts.
This award was established and first given in 2008 to recognize the outstanding achievement of a junior faculty-level scientist, and to provide support for cancer prevention research of significant scientific merit in any discipline across the continuum of research.

The AACR Gertrude B. Elion Cancer Research Award is open to tenure-track scientists at the level of assistant professor, who completed postdoctoral studies or clinical fellowships no more than four years prior to the start of the grant term. It provides a one-year grant of $50,000 for salary and benefits, supplies, equipment, and limited travel for the grant recipient. Projects may focus on research in cancer etiology, diagnosis, treatment or prevention (basic, translational or clinical cancer research).
The recipient of the 2011 award must attend the AACR 102nd Annual Meeting 2011 to accept the award and attend the AACR 103rd Annual Meeting 2012 to give a presentation of his or her research in a minisymposium.

International research collaboration can successfully address the global health problem of cancer through access to unique populations and environments, shared resources, specialized expertise, new concepts and perspectives, innovative methodologies and/or emerging technologies. However, barriers to sustaining these collaborations exist, such as the lack of funding as well as the lack of sharing of knowledge about these important research partnerships.
This award will support highly meritorious research that is being conducted collaboratively by investigators in different countries around the world.